Biomerica (BMRA) Deferred Taxes (2016)

Biomerica's (BMRA) quarterly Deferred Taxes came in at -$957000.0 in Q2 2016, down 865.6% quarter-over-quarter from $125000.0 in Q1 2016.

Biomerica (BMRA) Deferred Taxes (2016) Analysis & Trends

Biomerica has disclosed Deferred Taxes across 1 years of filings, most recently posting -$957000.0 for Q2 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -33.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -101.00 Mn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -351.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -9.40 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 300,000.00
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -16.70 Mn
10 Biomerica 5.57 Mn 4.23 Mn -44,000.00 -

Historic Data

Download Data
DateValue
May 31, 2016 -957,000.00
Feb 29, 2016 125,000.00